JPMorgan director defers quarterly retainer in stock
JPMorgan Chase & Co. director Stephen B. Burke reported a routine equity compensation transaction.
Rhea-AI Filing Summary
JPMorgan Chase & Co. director Stephen B. Burke reported a routine equity compensation transaction. He received 171.8449 shares of common stock on June 30, 2026 at $327.3300 per share as a grant or other acquisition, reflecting deferral of his quarterly director retainer into stock.
Following this award, he directly holds 208,303.1020 shares of common stock and indirectly holds 55,245 shares through a GRAT. The filing shows no open-market purchases or sales, only compensation-related and holding entries.
Positive
- None.
Negative
- None.
Insights
Routine director fee deferral into JPMorgan stock, no open-market trading.
Director Stephen B. Burke received 171.8449 JPMorgan common shares at $327.3300 per share as a grant or other acquisition. A footnote explains this reflects deferral of his quarterly retainer, payable in stock after his board service ends.
This is standard board compensation, not an open-market buy or sell, so it carries weak signaling value about his short-term view of the shares. After this transaction, he directly owns 208,303.1020 shares and indirectly 55,245 shares via a GRAT, indicating a substantial continuing equity stake.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 171.8449 | $327.33 | $56K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Deferral of quarterly retainer, payable in common stock following termination of service as director.
Key Figures
Key Terms
GRAT financial
quarterly retainer financial
grant, award, or other acquisition financial
FAQ
What did JPM director Stephen B. Burke report in this Form 4 for JPM?
Stephen B. Burke reported receiving 171.8449 JPMorgan common shares as a grant or other acquisition. The award reflects deferral of his quarterly director retainer into stock, rather than an open-market purchase or sale, making it routine compensation-related activity.
Was the JPM Form 4 filing for Stephen B. Burke a stock buy or sell?
The filing does not show any open-market buys or sells by Stephen B. Burke. It records a grant or other acquisition of 171.8449 common shares tied to deferred director fees, along with a separate holding entry for shares owned indirectly through a GRAT.
What price is associated with Stephen B. Burke’s JPM stock grant on June 30, 2026?
The grant to Stephen B. Burke is recorded at a price of $327.3300 per JPMorgan common share. This price is used for the 171.8449-share award that represents deferral of his quarterly retainer into stock-based compensation.
What does the GRAT reference mean in Stephen B. Burke’s JPM holdings?
The filing shows 55,245 JPMorgan shares held indirectly “By GRAT,” referring to a grantor retained annuity trust. This entity holds shares associated with Burke, separate from his 208,303.1020 directly owned shares reported after the June 30, 2026 transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.